1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Co.don AG
  6. News
  7. Summary
    CNWK   DE000A1K0227

CO.DON AG

(CNWK)
  Report
End-of-day quote Xetra  -  05-22
1.080 EUR   +0.93%
04/29CO.DON AG : Chairman of the Supervisory Board resigns for health reasons
PU
04/29Co.don AG Announces Resignation of Hans-B. Bauerfeind as Chairman of the Supervisory Board for Health Reasons
CI
03/28CO.DON AG : Spherox included on the list of pharmaceutical products reimbursed in Belgium
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CO.DON AG (ISIN: DE 000A3E5C08 / DE000A3E5C16): Preliminary Business Figures 2021

01/27/2022 | 09:09am EDT

Publication of insider information in accordance with article 17 of the Regulation (EU) No. 596/2014

Teltow / Leipzig, 27 January 2022, 2:45 PM - According to preliminary and yet unaudited figures, the Management Board of co.don Aktiengesellschaft, Teltow (ISIN DE000A3E5C08 / DE000A3E5C16; WKN AA3E5C0 / A3E5C1) ("Company") expects a consolidated result according to IFRS of approx. EUR -10.5 million for the past fiscal year 2021 (-24.3% compared to 2020; 2020: EUR -13.9 million). The Company will close the year 2021 significantly better than forecasted (Forecast for 2021: Group earnings between 7-14% moderately more positive compared to previous year or net profit in a corridor of EUR -12.0 and -13.0 million).

According to preliminary and yet unaudited figures, the Management Board also expects a significant improvement in the net loss for the year under German commercial law compared to the previous year. The Management Board anticipates approx. EUR -9.1 million (-33.3% in comparison to 2020; 2020: EUR -13.7 million). The Management Board had forecasted a moderate improvement of 10 - 20% compared to the previous year.

In terms of consolidated sales, the Executive Board anticipates sales of approx. EUR 9.8 million for the past fiscal year 2021 (+57.3% compared to 2020; 2020: EUR 6.2 million) based on preliminary and as of yet unaudited figures and sales in the individual financial statements of approx. EUR 9.1 million (+ 62.2% compared to 2020; 2020: EUR 5.6 million). This means that the Company will achieve its set target of increasing consolidated sales, as well as sales in the individual financial statements, by 50 - 70% compared to the previous year and achieving consolidated sales in the range of EUR 9.5 million and EUR 10.5 million.

The complete final and audited results for fiscal year 2021 will be published on April 29, 2021.

Notifying Person: Dr. Hans-Joachim Simons, Member of the Management Board

Contact

Matthias Meißner
Director Corporate Communications

Investor Relations / Public Relations
T: +49 (0)341 99190 330
F: +49 (0)341 99190 309
E: ir@codon.de

Disclaimer

co.don AG published this content on 27 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 January 2022 14:08:46 UTC.


© Publicnow 2022
All news about CO.DON AG
04/29CO.DON AG : Chairman of the Supervisory Board resigns for health reasons
PU
04/29Co.don AG Announces Resignation of Hans-B. Bauerfeind as Chairman of the Supervisory Bo..
CI
03/28CO.DON AG : Spherox included on the list of pharmaceutical products reimbursed in Belgium
PU
03/21CO.DON AG : CO.DON AG and JOINT OPERATIONS (UK) LLP sign contract for the distribution of ..
PU
03/21Co.Don AG and Joint Operations (Uk) LLP Sign Contract for the Distribution of Spherox i..
CI
03/01CO.DON AG : Recommendation to make EU marketing authorisation for Spherox valid for an unl..
PU
02/25CO.DON AG : Member of the Management Board resigns as of February 28, 2022
PU
02/25Co.don AG Announces Resignation of Hans-Joachim Simons as Member of the Executive Board..
CI
01/27CO.DON AG (ISIN : DE 000A3E5C08 / DE000A3E5C16): Preliminary Business Figures 2021
PU
01/27co.don AG Provides Consolidated Earnings Guidance for the Year 2021
CI
More news
Financials
Sales 2021 9,90 M 10,6 M 10,6 M
Net income 2021 -11,7 M -12,5 M -12,5 M
Net cash 2021 7,20 M 7,69 M 7,69 M
P/E ratio 2021 -2,92x
Yield 2021 -
Capitalization 23,6 M 25,3 M 25,2 M
EV / Sales 2021 1,66x
EV / Sales 2022 1,22x
Nbr of Employees -
Free-Float 41,6%
Chart CO.DON AG
Duration : Period :
co.don AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CO.DON AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,08 €
Average target price 4,90 €
Spread / Average Target 354%
EPS Revisions
Managers and Directors
Tilmann Bur Chief Executive Officer
Thomas Stählin Chairman-Supervisory Board
Barbara Sickmüller Member-Supervisory Board
Thomas Krause Member-Supervisory Board
Beatrix Bauerfeind-Johnson Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
CO.DON AG-34.15%25
CSL LIMITED-6.04%93 536
SAMSUNG BIOLOGICS CO.,LTD.-10.52%46 268
WUXI BIOLOGICS (CAYMAN) INC.-39.22%30 229
BIOGEN INC.-16.89%29 203
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-28.41%22 798